Show simple item record

dc.contributor.authorValencia, Catalina M.
dc.contributor.authorMol, Ben W.
dc.contributor.authorJacobsson, Bo
dc.contributor.authorthe FIGO Working Group for Preterm Birth
dc.date.accessioned2021-10-06T20:32:01Z
dc.date.available2021-10-06T20:32:01Z
dc.date.issued2021-10-01
dc.identifier.citationValencia , C M , Mol , B W , Jacobsson , B & the FIGO Working Group for Preterm Birth 2021 , ' FIGO good practice recommendations on modifiable causes of iatrogenic preterm birth ' , International Journal of Gynecology and Obstetrics , vol. 155 , no. 1 , pp. 8-12 . https://doi.org/10.1002/ijgo.13857en
dc.identifier.issn0020-7292
dc.identifier.otherPURE: 201501873
dc.identifier.otherPURE UUID: 8600e1e8-b8fe-4d9b-8889-21fb7c15d0c8
dc.identifier.otherScopus: 85115062482
dc.identifier.urihttps://hdl.handle.net/2164/17276
dc.descriptionFunding Information: Catalina M. Valencia reports no conflicts of interest. Ben W. Mol reports an investigator grant from NHMRC; consultancy for ObsEva; and research funding from Guerbet, Ferring, and Merck KGaA. Bo Jacobbson reports research grants from Swedish Research Council, Norwegian Research Council, March of Dimes, Burroughs Wellcome Fund and the US National Institute of Health; clinical diagnostic trials on NIPT with Ariosa (completed), Natera (ongoing), Vanadis (completed) and Hologic (ongoing) with expendidures reimbused per patient; clinical probiotic studies with product provided by FukoPharma (ongoing, no funding) and BioGaia (ongoing; also provided a research grant for the specific study); collaboration in IMPACT study where Roche, Perkin Elmer and Thermo Fisher provided reagents to PLGF analyses; coordination of scientific conferences and meetings with commercial partners as such as NNFM 2015, ESPBC 2016 and a Nordic educational meeting about NIPT and preeclampsia screening. Bo Jacobbson is also Chair of the FIGO Working Group for Preterm Birth and the European Association of Perinatal Medicine's special interest group of preterm delivery; steering group member of Genomic Medicine Sweden; chairs the Genomic Medicine Sweden complex diseases group; and is Swedish representative in the Nordic Society of Precision Medicine.en
dc.format.extent5
dc.language.isoeng
dc.relation.ispartofInternational Journal of Gynecology and Obstetricsen
dc.rightsThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.https://creativecommons.org/licenses/by/4.0/en
dc.subjectelective deliveryen
dc.subjectiatrogenic preterm birthen
dc.subjectmodifiable causesen
dc.subjectR Medicineen
dc.subjectObstetrics and Gynaecologyen
dc.subject.lccRen
dc.titleFIGO good practice recommendations on modifiable causes of iatrogenic preterm birthen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1002/ijgo.13857
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85115062482&partnerID=8YFLogxKen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record